Clinical Trials Browser

Phase 2 × famitinib × Dermatologic × Clear all

NCT05051865 2022-11-17

To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma

Phase 2 Unknown

Melanoma